MedTrace Logo

Effects of Blood Flow Restriction Training on Neuromuscular Function and Performance in Artistic Jump Rope Athletes

NCT07750977 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-08-06

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to investigate whether blood flow restriction training can improve physical function and sports performance in artistic jump rope athletes. The study will include 30 healthy artistic jump rope athletes aged 18 to 25 years. The main questions this study aims to answer are:

1. Does blood flow restriction training improve neuromuscular function compared with conventional training?
2. Does blood flow restriction training improve muscle strength, power, body composition, physiological responses, and artistic jump rope performance?

Researchers will compare participants receiving blood flow restriction training with participants performing conventional training to determine whether blood flow restriction training provides additional benefits. Participants will complete an 8-week training program and undergo assessments before and after the intervention, including muscle function tests, physical performance tests, body composition measurements, and physiological response evaluations.

Conditions

  • Neuromuscular Function
  • Athletic Performance Enhancement

Interventions

BEHAVIORAL

Blood Flow Restriction Training

An 8-week blood flow restriction training program combined with regular artistic jump rope training. External pressure will be applied using a blood flow restriction device during selected training sessions.

BEHAVIORAL

Conventional Artistic Jump Rope Training

An 8-week conventional artistic jump rope training program without blood flow restriction.

Sponsors & Collaborators

  • Shanghai University of Sport

    lead OTHER

Principal Investigators

  • kun Zhu, Professor · Shanghai University of Sport

  • Jing Wang, Student · Shanghai University of Sport

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-30
Primary Completion
2026-12-15
Completion
2026-12-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07750977 on ClinicalTrials.gov